Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Varenicline for Smoking Cessation
NCT00835900Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Mar 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in nicotine dependence, sponsored by Roswell Park Comprehensive Cancer Center. Started Mar 2009; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00835900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835900.